Cogent Biosciences COGT
NASDAQ COGT
$34.76 -0.19 (-0.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cogent Biosciences (COGT) Net Margin Growth (1y) (2018 - 2020)

Analysis

Cogent Biosciences (COGT) Net Margin Growth (1y) (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -763.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 529.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4,168.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 673.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2,208.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -392.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 29,636.00
10 Cogent Biosciences 5.94 Bn 5.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -1.72 Mn
Jun 30, 2020 -106,640.00
Mar 31, 2020 29,626.00
Dec 31, 2019 24,120.00
Sep 30, 2019 -67,122.00
Jun 30, 2019 20,648.00
Mar 31, 2019 -7,884.00
Dec 31, 2018 8,970.00
Sep 30, 2018 -19,671.00
Jun 30, 2018 -25,877.00
Mar 31, 2018 2,185.00